Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD)

C. Dali; N.W. Barton; Lars Peter Grüner Hanson; I. Krageloh-Mann; S. Groschel; C. Krarup; C. Hongmai; J. Ruis; M. Sellos-Moura; A.M. Lund

Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD)

C. Dali, N.W. Barton, Lars Peter Grüner Hanson, I. Krageloh-Mann, S. Groschel, C. Krarup, C. Hongmai, J. Ruis, M. Sellos-Moura, A.M. Lund

Funktions- og Billeddiagnostisk Enhed, MR-Forskningssektionen

Originalsprog	Udefineret/Ukendt
Publikationsdato	2011
Status	Udgivet - 2011
Begivenhed	European Pediatric Neurology Society Congress - Cavtat, Kroatien Varighed: 11 maj 2011 → 14 maj 2011

Konference

Konference	European Pediatric Neurology Society Congress
Land/Område	Kroatien
By	Cavtat
Periode	11/05/2011 → 14/05/2011

Citationsformater

Dali, C., Barton, N. W., Hanson, L. P. G., Krageloh-Mann, I., Groschel, S., Krarup, C., Hongmai, C., Ruis, J., Sellos-Moura, M., & Lund, A. M. (2011). Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD). Abstract fra European Pediatric Neurology Society Congress, Cavtat, Kroatien.

Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD). / Dali, C.; Barton, N.W.; Hanson, Lars Peter Grüner et al.
2011. Abstract fra European Pediatric Neurology Society Congress, Cavtat, Kroatien.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Dali, C, Barton, NW, Hanson, LPG, Krageloh-Mann, I, Groschel, S, Krarup, C, Hongmai, C, Ruis, J, Sellos-Moura, M & Lund, AM 2011, 'Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD)', European Pediatric Neurology Society Congress, Cavtat, Kroatien, 11/05/2011 - 14/05/2011.

@conference{a42ab6d0380c45e8a57efa66c414a37b,

title = "Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD)",

keywords = "TRIAL, Human, CHILDREN",

author = "C. Dali and N.W. Barton and Hanson, {Lars Peter Gr{\"u}ner} and I. Krageloh-Mann and S. Groschel and C. Krarup and C. Hongmai and J. Ruis and M. Sellos-Moura and A.M. Lund",

year = "2011",

language = "Udefineret/Ukendt",

note = "European Pediatric Neurology Society Congress ; Conference date: 11-05-2011 Through 14-05-2011",

}

TY - ABST

T1 - Outcome of a phase I/II trial of intravenous enzyme replacement with recombinant human arylsulfatase A (rhASA) in children with metachromatic leukodystrophy (MLD)

AU - Dali, C.

AU - Barton, N.W.

AU - Hanson, Lars Peter Grüner

AU - Krageloh-Mann, I.

AU - Groschel, S.

AU - Krarup, C.

AU - Hongmai, C.

AU - Ruis, J.

AU - Sellos-Moura, M.

AU - Lund, A.M.

PY - 2011

Y1 - 2011

KW - TRIAL

KW - Human

KW - CHILDREN

M3 - Konferenceabstrakt til konference

T2 - European Pediatric Neurology Society Congress

Y2 - 11 May 2011 through 14 May 2011

ER -